CHEP+ Clinical Practice Guidelines Program

Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease

Thursday November 12, 2020, • 7:00-9:00 PM ET

Presented by: Dr. Sheldon Tobe MD, FRCPC, MScCH (HPTE), FACP, FAHA

Dr. Tobe is a specialist in Hypertension and Nephrology, Division of Nephrology, Sunnybrook Health Sciences Centre, and is the University of Toronto Postgraduate Fellowship Director – Nephrology. He is a Professor in the Faculty of Medicine, University of Toronto and Northern Ontario School of Medicine (NOSM).

LEARNING OBJECTIVES

Upon completion of this case study, participants should be able to:

• Describe the rationale for anticoagulation of non-valvular atrial fibrillation
• Describe the effect on outcomes of non-valvular atrial fibrillation with CKD
• Describe the management of patients with CKD and non-valvular atrial fibrillation

Accreditation: This Group Learning program has been certified by the Canadian College of Family Physicians for up to 6 Mainpro+ credits for the 2-hour presentation including a practice reflection survey to be completed at 6 weeks post-session.

You will receive an email before the event with the details on how to join using Microsoft Teams Online.

This session was supported in part by an educational grant from the BMS Pfizer Alliance.

FAQs

• How can I contact the organizer with any questions? To contact the organizer, email: Diane Hua-Stewart at Diane.Hua@sunnybrook.ca / (416) 710-3892.

• To learn more: Please visit the event website: https://www.cchangeguidelines.com/